ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Chembest Research Laboratories Limited  
Tel: 021-20908456
Email: sales@BioChemBest.com
Company Name: BeiJing Hwrk Chemicals Limted  
Tel: 0757-86329057 18934348241
Email: sales4.gd@hwrkchemical.com
Company Name: JinYan Chemicals(ShangHai) Co.,Ltd.  
Tel: 13817811078
Email: sales@jingyan-chemical.com
Company Name: Adamas Reagent, Ltd.  
Tel: 4006009262 13023226327
Email: hmj@titansci.com

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine manufacturers

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Basic information
Product Name:(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
Synonyms:(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine;(Cis)-Benzyl-N,4-diMethylpiperidin-3-aMine;(3R,4R)-1-benzyl-N,4-diMethylpiperidin-3-aMine hydrochloride;3-PiperidinaMine, N,4-diMethyl-1-(phenylMethyl)-, (3R,4R)-;(3R,4R)-1-Benzyl-N,4-diMe...;(3R,4R)-1-Benzyl-N-Methyl-4-Methylpiperidin-3-aMine;(3R,4R)-1-BENYL-N,4-DIMETHYLPIPERIDIN-3-AMINE;(3R,4R)-N,4-DiMethyl-1-benzyl-3-piperidinaMine
CAS:477600-70-7
MF:C14H22N2
MW:218.34
EINECS:
Product Categories:
Mol File:477600-70-7.mol
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Structure
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Chemical Properties
Boiling point 302.6±35.0 °C(Predicted)
density 1.00±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,Room temperature
pka10.26±0.40(Predicted)
AppearanceColorless to light yellow Liquid
InChIInChI=1S/C14H22N2/c1-12-8-9-16(11-14(12)15-2)10-13-6-4-3-5-7-13/h3-7,12,14-15H,8-11H2,1-2H3/t12-,14+/m1/s1
InChIKeyNVKDDQBZODSEIN-OCCSQVGLSA-N
SMILESN1(CC2=CC=CC=C2)CC[C@@H](C)[C@@H](NC)C1
Safety Information
HS Code 2933399990
MSDS Information
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine Usage And Synthesis
Uses(3R,4R)-N,4-Dimethyl-1-benzyl-3-piperidinamine (D464895) is a reagent used in the preparation of Janus tyrosine kinase inhibitors for the treatment of autoimmune diseases.
Synthesis
Pyridinium, 4-methyl-3-(methylamino)-1-(phenylmethyl)-, bromide (1:1)

1615709-89-1

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine

477600-70-7

The general procedure for the synthesis of (3R,4R)-1-benzyl-4-methyl-3-(methylamino)pyridin-1-ium bromide as a raw material for the synthesis of (3R,4R)-1-benzyl-4-methyl-3-methylamino-piperidines was as follows: 1-benzyl-3-methylamino-4-methyl-pyridinium bromide (10 g, 34.1 mmol) was placed in a 250 ml reaction flask, ethanol (100 g) was added, and a temperature of below 30°C and stirring was started. Sodium borohydride (3.87 g, 102.3 mmol) was added slowly and after addition, the reaction was continued with stirring for 16 h. The reaction was monitored by HPLC until the content of raw material was below 1%. Subsequently, 2M HCl solution was slowly added dropwise to the reaction system until no bubbles were generated. The reaction solution was concentrated to one third of the original volume under reduced pressure. It was extracted twice with dichloromethane, the organic phases were combined and concentrated under reduced pressure to remove the solvent. To the resulting crude product, ethanol (40 g) was added and 2M hydrochloric acid ethanol solution (20 ml) was slowly added dropwise at a temperature below 30 °C. A solid precipitated. After dropwise addition, stirring was continued for 1 h. Subsequently, filtration was carried out and the filter cake was dried under reduced pressure. The final white solid product (3R,4R)-1-benzyl-4-methyl-3-methylamino-piperidine (6.9 g, 23.8 mmol) was obtained in 70% yield.

References[1] Patent: CN108610279, 2018, A. Location in patent: Paragraph 0014; 0016
Tag:(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine(477600-70-7) Related Product Information
Chloropretadalafil cis-Octahydroisoindole Tetrahydro-5-oxo-2- furancarboxyli cis-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate cis-3-azabicyclo[3,3,0]oct-2-ene (2S,4S)-4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (+)-(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester Tofacitinib Impurity 6 (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) 3-bis(4-Methylbenzoyloxy)succinate) 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 2,4-Dichloro-7H-pyrrolo2,3-dpyrimidine